NKNaryeong Kim

Naryeong Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Naryeong Kim has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Direct cortical stimulation induces short-term modulation of neural oscillations in humans

    by Saachi Munot, Naryeong Kim, Yuhao Huang, Corey J. Keller

    Brain stimulation treats neuropsychiatric disorders, yet spectral changes remain poorly understood. We performed patterned stimulation in epilepsy patients, using intracranial recordings to study oscillatory plasticity. We found predictable changes: low frequencies were widespread, whereas high frequencies showed greater magnitude. These shifts were predicted by prestimulation activity. Our study reveals that baseline brain states determine spectral plasticity, providing insights to optimize stimulation techniques and understand human brain dynamics.

  • Open Access

    Mass Spectrometry in Allogeneic CAR-T Cell Manufacturing: From Cellular Starting Materials to Multi-Attribute Quality Control

    by Naryeong Kim, Zhouyang Huang, Michael Born, Julien Camperi

    Chimeric antigen receptor (CAR) T-cell therapies have demonstrated remarkable clinical efficacy in hematological malignancies, yet their broader application is constrained by manufacturing complexity and variability, particularly in autologous settings. The development of allogeneic CAR T-cell therapies offers a promising alternative by enabling scalable, “off-the-shelf” production; however, these approaches introduce additional challenges related to donor variability, genome editing, and product consistency. Robust analytical strategies are therefore required to ensure safety, efficacy, and batch-to-batch reproducibility. Conventional analytical methods, such as flow cytometry and enzyme-linked immunosorbent assays, provide targeted, high-confidence measurements of predefined cellular and soluble markers but are inherently limited in their ability to capture the full molecular and functional complexity of CAR T-cell products. In current manufacturing paradigms, these assays are typically deployed as isolated quality control readouts rather than as components of an integrated control strategy that links donor variability, gene-editing material quality, in-process metabolic state, final product critical quality attributes, and clinical biomarker responses. In this context, mass spectrometry (MS) has emerged as a powerful platform for high-dimensional molecular characterization, enabling analysis of gene-editing reagents, proteins, metabolites, lipids, and both culture and spent-media composition across the CAR T-cell manufacturing workflow. In this review, we examine the various applications and tools of MS across key stages of the allogeneic CAR T-cell workflow, including donor characterization, analysis of gene-editing materials, in-process culture monitoring, drug product quality assessment, and post-infusion biomarker evaluation. Collectively, these approaches demonstrate the potential of MS-driven analytics to address current limitations in CAR T-cell manufacturing by improving process understanding, enabling comprehensive quality assessment, and supporting regulatory decision-making. The integration of MS into CAR T-cell workflows may ultimately facilitate the development of more consistent, scalable, and effective cell therapies.

  • Open Access

    Cognitive load modulates cortical excitability in the human prefrontal cortex

    by Umair Hassan, Lily Forman, James W. Hartford, Hansong Lee, Sara Parmigiani, Nai-Feng Chen, Jessica M. Ross, Ethan A. Solomon, Juha Gogulski, Naryeong Kim, et al.

    The prefrontal cortex dynamically adjusts its excitability to meet changing cognitive demands, yet our understanding of how these rapid state changes unfold in real time remains limited. Existing evidence relies predominantly on correlational neuroimaging and invasive electrophysiology in clinical populations, neither of which affords causal measurement in healthy humans. Here, using concurrent single-pulse TMS-EEG during a parametric cognitive multi-source interference task (MSIT) in 27 healthy participants, we causally probed left prefrontal excitability across conditions spanning a range of cognitive interference levels. Prefrontal excitability scaled systematically with cognitive load, peaking at intermediate incongruency levels where trial-type uncertainty was greatest, and differentiating high-from low-conflict trials at the single-subject level. Critically, prefrontal excitability and midfrontal theta power showed parallel state dependency patterns, linking causal perturbation of prefrontal circuit responsiveness to an established oscillatory marker of cognitive control. The observed excitability modulation was selective to the left prefrontal cortex: stimulation of right dlPFC, pre-SMA, and vertex in a separate control cohort (N=5) produced no load-dependent effects. These results position prefrontal excitability as a real-time, regionally selective physiological readout of how the human prefrontal cortex adapts to cognitive demand. Highlights: We evaluated the links between cognitive interference, prefrontal excitability, and intrinsic theta activity during a multi-source interference task Cognitive load, estimated based on behavioral performance, was greatest at at intermediate interference levels (33% congruent), where trial-type uncertainty was maximal Prefrontal excitability, measured via single-pulse TMS-evoked potentials, scaled with cognitive load Effects were observed at the single subject level and were specific to prefrontal stimulation Prefrontal excitability changes and midfrontal theta power showed parallel scaling with cognitive load, linking causal probing to established oscillatory markers This noninvasive technique provides causal measurement of prefrontal engagement during cognitive processing The methodology demonstrates potential for tracking brain state dynamics in both healthy cognition and neuropsychiatric disorders


  • Open Access

    bFGF Oligomeric Stability Drives Functional Performance in Human Pluripotent Stem Cells

    by Dylan E. Iannitelli, Naryeong Kim, Luladey Ayalew, Qiang Wu, Xinzheng Victor Guo, Kyle Spitler, Manasa P. Srikanth, Julien Camperi

    Basic fibroblast growth factor (bFGF) and Transforming growth factor-beta (TGF-β) are key regulators of human pluripotent stem cell (hPSC) maintenance, supporting pluripotency and self-renewal. bFGF is particularly critical for sustaining the undifferentiated state and is commonly supplied through feeder-derived conditioned media. Similarly, TGF-β promotes hPSC expansion by modulating signaling pathways and contributing to a supportive stem cell niche. In this study, we investigated how the quality and variability of these growth factors influence hPSC culture performance. To address this, we developed and applied multiple physicochemical characterization methods—including size exclusion and reverse-phase chromatography—to assess growth factor purity and identify impurities across different material sources. Our findings show that certain post-translational modifications in TGF-β (e.g., oxidized variants) did not measurably affect hPSC culture. However, high temperature-dependent instability of bFGF preparations significantly altered hPSC morphology and growth. These findings underscore the need for improved quality control of growth factor components in culture media to ensure consistent hPSC maintenance, thus decreasing variability across experiments. This study highlights the value of correlating analytical physicochemical data with process performance, thereby advancing material understanding, enabling more efficient process development, and facilitating the identification of critical material attributes that affect the quality of cell therapy products.